 |
|
Update on Adjuvant Treatment in Resectable Non-Small Cell Lung Cancer and Potential Biomarkers Predicting Postoperative Relapse
Jeong Uk Lim
Tuberc Respir Dis. 2023;86(1):14-22. Published online 2022 Oct 26 DOI: https://doi.org/10.4046/trd.2022.0081
|
|
Citations to this article as recorded by
 New targeted therapies for non-small cell lung cancer
Eun Hye Lee, Se Hyun Kwak, Chi Young Kim, Hye Ran Gwon, Eun Young Kim, Yoon Soo Chang
Journal of the Korean Medical Association.2023; 66(3): 180. CrossRef Economic burden of early-stage non-small-cell lung cancer: an assessment of healthcare resource utilization and medical costs
Jon Apple, Maral DerSarkissian, Anne Shah, Rose Chang, Yan Chen, Xuanhao He, Justin Chun
Journal of Comparative Effectiveness Research.2023;[Epub] CrossRef
|